Attached files

file filename
10-K - FORM 10-K - EPIRUS Biopharmaceuticals, Inc.d10k.htm
EX-32.1 - CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 - EPIRUS Biopharmaceuticals, Inc.dex321.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - EPIRUS Biopharmaceuticals, Inc.dex231.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.dex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.dex311.htm
EX-10.54 - SUB-LEASE RENEWAL AND AMENDMENT AGREEMENT - EPIRUS Biopharmaceuticals, Inc.dex1054.htm
EX-10.56 - SECOND AMENDMENT TO LEASE AGREEMENT - EPIRUS Biopharmaceuticals, Inc.dex1056.htm

Exhibit 21.1

Subsidiaries of CombinatoRx, Incorporated

CombinatoRx Securities Corporation—incorporated in Massachusetts

Neuromed Pharmaceuticals Ltd.—formed in British Columbia

Neuromed Development Inc.—incorporated in Barbados

Neuromed Pharmaceuticals Inc.—incorporated in Delaware

Neuromed Acquisition Corporation—incorporated in Delaware

0797733 B.C. Ltd.—formed in British Columbia